检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Refining neutropenia risk assessment in patients treated with first-line endocrine therapy (ET) and cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) for metastatic breast cancer (MBC) through a cell-free DNA workflow (cfDNA).

Lorenza Palmero,Roberta Mazzeo,Silvia Buriolla,Lorenzo Allegri,Lucia Bortot,Alessandra Franzoni,Anna Michelotti, Elisabetta Camilla Stefani, Giulia Turra, Miriam Zilli,Paola Di Nardo,Rossana Roncato,Marta Bonotto,Erika Cecchin,Barbara Belletti,Giuseppe Toffoli,Lorenzo Gerratana,Gustavo Baldassarre,Giuseppe Damante,Fabio Puglisi

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 2|浏览15
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要